152 results
8-K
EX-99.1
NTLA
Intellia Therapeutics Inc
9 May 24
Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
7:40am
”) within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, express
8-K
EX-99.1
NTLA
Intellia Therapeutics Inc
15 Apr 24
Departure of Directors or Certain Officers
4:21pm
” or the “Company”) within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited
8-K
g9jxxez
22 Mar 24
Termination of a Material Definitive Agreement
9:26am
424B5
jwuaotepkiqj02ozv7b
26 Feb 24
Prospectus supplement for primary offering
7:04am
424B5
ptveo
23 Feb 24
Prospectus supplement for primary offering
5:22pm
8-K
EX-99.1
swk0zgk6ovucx99s
22 Feb 24
Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress
7:45am
8-K
EX-99.1
ck4o25byj6a5tnt
1 Feb 24
Regulation FD Disclosure
4:05pm
8-K
EX-99.1
96779cc
4 Jan 24
Intellia Therapeutics Highlights its Three-Year Strategic Priorities and Anticipated 2024 Key Milestones
4:07pm
8-K
by46z8fvejcmi7
4 Jan 24
Intellia Therapeutics Highlights its Three-Year Strategic Priorities and Anticipated 2024 Key Milestones
4:07pm
8-K
EX-99.1
7rlp8dl 384
9 Nov 23
Intellia Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
7:45am
8-K
r90y9e866bknp02cf41
2 Nov 23
Intellia Presents New Interim Data from the Ongoing Phase 1 Study of NTLA-2001 at the 4th International ATTR Amyloidosis Meeting
7:11am
8-K
EX-99.1
9wulak3rrlr si83lh
2 Nov 23
Intellia Presents New Interim Data from the Ongoing Phase 1 Study of NTLA-2001 at the 4th International ATTR Amyloidosis Meeting
7:11am
8-K
nckzci
18 Oct 23
Intellia Therapeutics Announces FDA Clearance of
7:30am
8-K
EX-99.1
i7askdlw
18 Oct 23
Intellia Therapeutics Announces FDA Clearance of
7:30am
8-K
cq3jsc5ws 589sk1x9
3 Oct 23
Regeneron and Intellia Announce Expanded Research Collaboration
7:19am